Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pain relieving and serum uric acid decreasing medicinal tea for preventing and treating gouty arthritis

A technology for gouty arthritis and pain relief, applied in the direction of antipyretics, anti-inflammatory agents, drug combinations, etc., can solve the problem of unsatisfactory curative effect, achieve the effect of relieving acute gouty joint redness, swelling and pain, and good curative effect

Active Publication Date: 2018-10-09
孙益
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] There are many types of methods for preventing and treating gouty arthritis in the prior art, including traditional Chinese medicine, western medicine, surgery, etc., but the curative effects are not ideal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Clinical studies:

[0036] 1.1 General information

[0037] In this study, according to the inclusion and exclusion criteria, a total of 100 cases were collected, all of whom were male, who were outpatients and inpatients in our hospital. According to the random number control table, they were divided into the control group and the experimental group with 50 cases each. In the control group, the youngest age was 28 years old, the oldest age was 79 years old, and the average age was 52 years old, including 6 patients with initial onset and 3 patients with tophi. In the experimental group, the youngest age was 27 years old, the oldest was 79 years old, and the average age was 52 years old, including 8 patients with initial onset and 2 patients with tophi. There was no significant difference between the two groups in the age of onset, course of disease, and distribution of syndrome types (P>0.05), which were comparable.

[0038] 1.2 Diagnostic criteria

[0039]According...

Embodiment 2

[0065] Clinical studies:

[0066] 1.1 General information

[0067] According to the inclusion and exclusion criteria, this study collected a total of 50 cases, all male, who were outpatients and inpatients in our hospital. They were divided into the control group and the experimental group with 25 cases in each group according to the random number control table. In the control group, the youngest age was 25 years old, the oldest was 75 years old, and the average age was 48 years old, including 7 patients with initial onset and 1 patient with tophi. The youngest age in the experimental group was 23 years old, the oldest was 75 years old, and the average age was 47 years old. Among them, 6 cases were first-onset patients and 2 cases were associated with tophi. There was no significant difference between the two groups in the age of onset, course of disease, and distribution of syndrome types (P>0.05), which were comparable.

[0068] 1.2 Diagnostic criteria

[0069] According ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of traditional Chinese medicine, and discloses a pain relieving and serum uric acid decreasing medicinal tea for preventing and treating gouty arthritis. The tea comprises the following components in parts by weight: 10-14 parts of cassia twig, 10-14 parts of honeysuckle stem, 8-12 parts of large-leaved gentian, 8-12 parts of radix clematidis, 8-12 parts of crotalaria sessiiflora, 8-12 parts of rhizoma smilacis glabrae, 6-10 parts of grifola, 6-10 parts of semen plantaginis, 6-10 parts of rhizoma alismatis, 4-8 parts of radix paeoniae alba, and 4-8 parts of radix bupleuri. The pain relieving and serum uric acid decreasing medicinal tea is suitable for paints with gouty arthritis and hyperuricemia and has the functions of relieving acute gout caused redness, swelling and pain of joints and other symptoms and also has the effect of decreasing serum uric acid.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a pain-removing and acid-reducing medicinal tea for preventing and treating gouty arthritis. Background technique [0002] Gouty arthritis is caused by the deposition of urate in the joint capsule, bursa, cartilage, bone and other tissues, causing lesions and inflammatory reactions. It is mostly genetic, and it usually occurs in men over the age of 40. It is more common in The first metatarsophalangeal joint can also occur in other larger joints, especially the ankle and foot joints. [0003] Causes of gouty arthritis: Uric acid is the end product of purine metabolism. Gout is caused by long-term purine metabolism disorder and increased blood uric acid. If the patient has no clinical symptoms and the concentration of uric acid in the blood is higher than the normal value, it is medically called "hyperuricemia". If the concentration of uric acid in the blood reaches...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/90A61K36/896A61P19/02A61P19/06A61P29/00
CPCA61K9/0095A61K36/07A61K36/233A61K36/355A61K36/48A61K36/515A61K36/54A61K36/65A61K36/68A61K36/71A61K36/716A61K36/884A61K36/896A61K36/90A61P19/02A61P19/06A61P29/00A61K2300/00
Inventor 孙益
Owner 孙益
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com